Bulletin

Investor Alert

London Markets Open in:

Asia Markets Currencies US Market Snapshot

AstraZeneca PLC ADR

NAS: AZN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

AstraZeneca PLC ADR

After Hours

AZN

/zigman2/quotes/200304487/composite

56.88

Change

-0.09 -0.16%

Volume

Volume 12,336

Jan 24, 2022, 7:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200304487/composite

Previous close

$ 59.10

$ 56.97

Change

-2.13 -3.60%

Day low

Day high

$55.50

$57.77

Open: 57.73

52 week low

52 week high

$46.48

$64.21

Market cap

$183.80B

Average volume

5.09M

P/E ratio

89.91

Rev. per Employee

$452,181

EPS

0.63

Dividend

0.45

Div yield

2.40%

Ex dividend date

8/12/21

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/azn

MarketWatch News on AZN

Moderna Inc. stock falls Monday, underperforms market

4:31 p.m. Jan. 24, 2022

- MarketWatch Automation
AstraZeneca says drug for rare, fatal condition gets orphan-drug designation

7:50 a.m. Jan. 24, 2022

- Jaimy Lee
Investors Can Change The Course of This Pandemic

4:00 a.m. Jan. 24, 2022

- Peter Singer
Moderna Inc. stock falls Friday, underperforms market

4:31 p.m. Jan. 21, 2022

- MarketWatch Automation
Moderna Inc. stock underperforms Thursday when compared to competitors

4:31 p.m. Jan. 20, 2022

- MarketWatch Automation
Moderna Inc. stock falls Wednesday, underperforms market

4:31 p.m. Jan. 19, 2022

- MarketWatch Automation
Moderna Inc. stock falls Tuesday, underperforms market

4:31 p.m. Jan. 18, 2022

- MarketWatch Automation
Sanofi CEO Says Vaccine Incumbents Are Set to Win

4:00 a.m. Jan. 17, 2022

- Josh Nathan-Kazis
Moderna Inc. stock falls Friday, underperforms market

4:31 p.m. Jan. 14, 2022

- MarketWatch Automation
Citigroup Says 99% of U.S. Staff Comply With Covid Vaccine Mandate

6:52 a.m. Jan. 14, 2022

- Lina Saigol
Moderna Inc. stock falls Thursday, underperforms market

4:31 p.m. Jan. 13, 2022

- MarketWatch Automation
Moderna Inc. stock outperforms market on strong trading day

4:31 p.m. Jan. 12, 2022

- MarketWatch Automation
China Blocks Some U.S. Flights After Passengers Get Covid-19

6:04 a.m. Jan. 12, 2022
Moderna Inc. stock underperforms Tuesday when compared to competitors

4:31 p.m. Jan. 11, 2022

- MarketWatch Automation
London stocks ride a global bounce, with retailers and energy names higher

10:03 a.m. Jan. 11, 2022

- Barbara Kollmeyer
Moderna Inc. stock rises Monday, outperforms market

4:31 p.m. Jan. 10, 2022

- MarketWatch Automation
Moderna Inc. stock falls Friday, underperforms market

4:31 p.m. Jan. 7, 2022

- MarketWatch Automation
Moderna Inc. stock rises Thursday, outperforms market

4:31 p.m. Jan. 6, 2022

- MarketWatch Automation
Moderna Inc. stock falls Wednesday, underperforms market

4:31 p.m. Jan. 5, 2022

- MarketWatch Automation
Moderna Inc. stock falls Tuesday, still outperforms market

4:31 p.m. Jan. 4, 2022

- MarketWatch Automation
Loading more headlines...

Analyst Ratings

Analysts’ Recommendations for Valeant in June

12:04 p.m. June 8, 2018

- MarketRealist.com
Barclays Downgrades Pfizer Stock and Cuts Price Target

7:24 a.m. April 11, 2018

- MarketRealist.com
Benzinga's Top Upgrades, Downgrades For March 19, 2018

8:11 a.m. March 19, 2018

- Benzinga.com

/news/nonmarketwatch/company/us/azn

Other News on AZN

Omicron blunts rise in vaccine sales for 2022, health analytics firm says

12:07 p.m. Jan. 24, 2022

- Seeking Alpha
3 Unstoppable Biotech Stocks to Buy Right Now

6:04 a.m. Jan. 24, 2022

- Motley Fool
How the future for COVID-19 boosters could impact vaccine names

4:00 p.m. Jan. 22, 2022

- Seeking Alpha
AstraZeneca And The COVID-19 Vaccine: The Financials

8:32 a.m. Jan. 22, 2022

- Seeking Alpha
Community Trust & Investment Co Buys Cheniere Energy Inc, Salesforce. ...

4:38 p.m. Jan. 21, 2022

- GuruFocus.com
Judge blocks Biden mandate requiring COVID vaccination for federal employees

2:04 p.m. Jan. 21, 2022

- Seeking Alpha
Pharma Stock Roundup: GSK's Consumer Unit Offer Rejection, FDA Updates for AZN, PFE

10:00 a.m. Jan. 21, 2022

- Zacks.com
GlaxoSmithKline Racing to Provide Only Effective Covid-19 Antibody Treatment

8:00 a.m. Jan. 21, 2022

- Denise Roland
Is Ocugen Stock a Buy Now?

10:30 a.m. Jan. 20, 2022

- Motley Fool
CDC study finds prior infection provides better immunity against COVID than vaccines

10:10 a.m. Jan. 20, 2022

- Seeking Alpha
Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant

10:04 a.m. Jan. 20, 2022

- Zacks.com
Biden again says not going back to lockdowns, on way to life without COVID disruptions

4:42 p.m. Jan. 19, 2022

- Seeking Alpha
Small South African study finds mRNA COVID boosters don't prevent Omicron infections

8:31 a.m. Jan. 19, 2022

- Seeking Alpha
3 Under-the-Radar COVID Stocks

7:55 a.m. Jan. 19, 2022

- Motley Fool
AstraZeneca's Imfinzi + CTLA-4 inhibitor improves survival as liver cancer treatment

6:29 p.m. Jan. 18, 2022

- Seeking Alpha
Will Moderna (MRNA) Continue to Ride on Vaccine Sales in 2022?

10:34 a.m. Jan. 18, 2022

- Zacks.com
AstraZeneca (AZN) Enhertu sBLA Receives FDA Priority Tag

10:06 a.m. Jan. 18, 2022

- Zacks.com
Here's Some Good News for Novavax That Investors Are Overlooking

7:42 a.m. Jan. 18, 2022

- Motley Fool
This Could Be Another Blockbuster Indication for AstraZeneca

7:00 a.m. Jan. 17, 2022

- Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich

10:30 a.m. Jan. 16, 2022

- Motley Fool
Loading more headlines...

/news/pressrelease/company/us/azn

Press Releases on AZN

Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis

7:10 a.m. Jan. 24, 2022

- BusinessWire - BZX
Covid Stocks Could Represent Huge Value on Sale (NVAX, OTLC, PFE, AZN, MRNA, MRK, JNJ, BNTX)

7:15 a.m. Jan. 21, 2022

- WallStreetPR
IMFINZI® (durvalumab)Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer

7:13 p.m. Jan. 18, 2022

- BusinessWire - BZX
IMFINZI® (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years

7:13 p.m. Jan. 18, 2022

- BusinessWire - BZX
CORRECTING and REPLACING ENHERTU® granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

7:41 p.m. Jan. 17, 2022

- BusinessWire - BZX
Enhertu Granted Priority Review in the US for Patients With HER2-Positive Metastatic Breast Cancer Treated With a Prior Anti-HER2-Based Regimen

7:00 a.m. Jan. 17, 2022

- BusinessWire - BZX
AstraZeneca Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment With Practice-Changing IMFINZI® (durvalumab)and LYNPARZA® (olaparib)Data at ASCO GI and GU

7:05 a.m. Jan. 13, 2022

- BusinessWire - BZX
TEZSPIRE Now Available in the United States for the Treatment of Severe Asthma

7:00 a.m. Jan. 13, 2022

- BusinessWire - BZX
Gritstone Slips on Vaccine News

10:12 a.m. Jan. 4, 2022

- Baystreet.ca
Why 2022 Could Open Gangbusters for Covid Stocks (AZN, OTLC, NVAX, PFE, MRNA, MRK, JNJ, BNTX)

2:08 p.m. Jan. 3, 2022

- ABNewswire
Why 2022 Could Open Gangbusters for Covid Stocks (AZN, OTLC, NVAX, PFE, MRNA, MRK, JNJ, BNTX)

7:15 a.m. Dec. 31, 2021

- WallStreetPR
Thinking about trading options or stock in Tesla, Scientific Games, Novavax, Moderna, or AstraZeneca?

9:31 a.m. Dec. 23, 2021

- PR Newswire - PRF
EVUSHELDlong-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities

7:00 a.m. Dec. 23, 2021

- BusinessWire - BZX
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study

9:58 a.m. Dec. 16, 2021

- BusinessWire - BZX
EnWave Reports Fourth Quarter and Annual 2021 Consolidated Financial Results

8:00 a.m. Dec. 16, 2021

- GlobeNewswire
Covid Stocks Set for Continued Interest on Global Omicron Surge (NVAX, OTLC, PFE, AZN, MRNA, MRK, JNJ, BNTX)

7:33 a.m. Dec. 15, 2021

- WallStreetPR
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

7:55 p.m. Dec. 13, 2021

- PR Newswire - PRF
CALQUENCE reduced the risk of disease progression or death by 71% vs. standard of care combinations at three years in the ASCEND Phase III trial

2:48 p.m. Dec. 12, 2021

- BusinessWire - BZX
ENHERTU® (fam-trastuzumab deruxtecan-nxki)Additional Analyses Further Reinforce Ground-breaking Efficacy in Patients With HER2-positive Metastatic Breast Cancer

10:05 a.m. Dec. 9, 2021

- BusinessWire - BZX
EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

7:37 p.m. Dec. 8, 2021

- BusinessWire - BZX
Loading more headlines...

Rates »

Mortgage Equity Savings Auto

National averages from Bankrate.com

Trending Tickers

/zigman2/quotes/202561856/composite MSTR-17.84%
/zigman2/quotes/205315244/composite DHT-4.09%

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

AstraZeneca PLC ADR

MarketWatch News on AZN

Analyst Ratings

Other News on AZN

Press Releases on AZN

Rates »

Latest News

dow

nasdaq

s&p 500

Kiosk